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Abstract 
Introduction: In Indonesia, cases of hydrocephalus in children are found in 40% to 50% of medical visits 
or neurosurgical operations. Endoscopic third ventriculostomy was one of choices for treat the patient but 
efficacy and effects still unknown. Purpose of this study is to broadly assess the outcome of treatments 
and review evidence that one treatment may have greater efficacy than another.  
Method: Researchers develop PICO questions. Demographic information, detailed methods, 
interventions, and results were extracted from the selected manuscripts. Of the 122 articles identified 
using optimized search parameters, 52 were withdrawn for full-text review. In total, 6 articles were 
accepted for inclusion in the evidentiary table and 8 were excluded for various reasons.  
Result: The tabulated evidence provides sufficient data to allow our evaluation of the CSF versus ETV 
shunt.  
Conclusion: CSF shunt and endoscopic third ventriculostomy (ETV) are options in the management of 
hydrocephalus in children 
Keyword: Endoscopic third ventriculostomy, Hydrocephalus, Ventriculo-peritoneal Shunt 
Introduction 
Hydrocephalus is one of the most common diseases in children. In developed 
countries, the prevalence of congenital hydrocephalus is 0.5-1 per 1000 live births. 
Meanwhile, the prevalence of hydrocephalus is 3 to 5 per 1000 live births. The 
prevalence of idiopathic normal pressure hydrocephalus (iNPH) has been reported to be 
1.8-2.2 cases per 100,000 and 1,000,000 people, respectively. In Indonesia, cases of 
hydrocephalus in children are found in 40% to 50% of medical visits or neurosurgical 
operations. A research showed that the incidence of pediatric hydrocephalus 
communicants and non-communicants in Dr. Soetomo Surabaya from January 2014 to 
January 2016 amounted to 35.9% and 51.1% [1].In order to properly understand 
hydrocephalus, it is first necessary to discuss the production and absorption of 
cerebrospinal fluid (CSF) and its pathways. CSF is mainly produced by the choroid 
plexuses in the lateral, third, and fourth ventricles. The ependymal and capillary cells 
also play a minor role in CSF secretion. Through arachnoid granulation, CSF will flow 
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into the venous sinuses and then to the lymphatic system through the Virchow-Robin 
space. Furthermore, most of it will flow to the craniospinal nerves via the perineural 
space; while some will flow to the spinal cord. CSF circulates in the cerebral ventricles 
(lateral, ventricles and third and fourth waterways) and cerebrospinal Subarachnoid 
Space (SAS). [2] In general, the CSF volume is about 160 mL wherein 25% of this 
volume circulates in the ventricles and 75% in the spinal and subarachnoid cortical 
spaces. The average CSF production rate was 0.34 ± 0.13 mL / minute; the average CSF 
absorption rate in the spinal cord was 0.17 mL / minute. It should be pointed out that 
under normal physiological conditions, circulating CSF has a constant inflow and pulse. 
[3] 
The most important hydrodynamic parameter that indicates the incidence of 
hydrocephalus is the CSF Intracranial Pressure (ICP) which refers to the numerical 
value of the CSF pressure in the upper brain convex in SAS. It should be noted that the 
ICP wave is different from the Arterial Blood Pressure (ABP) wave. The ICP values in 
normal infants under one year of age, children, and adults are 3-4 mm Hg, 11 mm Hg, 
and 10-15 mm Hg, respectively. Many CSF circulation parameters such as CSF flow 
rate and flow rate diagrams for patients with hydrocephalus and healthy subjects are 
measured via contrast Cine Magnetic Resonance Imaging (Cine PC-MRI)[4]. 
Meanwhile, these tools are more useful for understanding patient pathophysiology. The 
choice of the appropriate surgical method - insertion of a CSF shunt or endoscopic third 
ventriculostomy (ETV) - for the management of hydrocephalus in children remains a 
topic of debate. Proponents of ETV cite the low failure rate and the potential to avoid 
shunt placement and the inherent risks as the main advantages of this procedure, while 
proponents of ventriculoperitoneal shunt (VP) insertion have questioned the efficacy of 
ETV in treating hydrocephalus as well as the unknown effects of ETV on 
neurodevelopment and quality of life. [5] 
Although there is a large literature on CSF and ETV shunts, there is a relative 
dearth of articles describing evaluations of CSF and ETV shunt placement, and no 
randomized trials comparing the two procedures. ETV may be useful in cases where 
there is clear obstruction to the CSF stream and ETV provides an alternative pathway. It 
is less certain that ETV has an advantage over shunts in many other causes of 
hydrocephalus. There has been much interest in the use of ETV with choroid plexus 
coagulation (CPC) in the management of infant hydrocephalus. [6] 
The Pediatric Hydrocephalus Systematic Review and Evidence-Based 
Guidelines Task Force anticipates that this topic, together with the effectiveness of ETV 
compared to shorthand in treating hydrocephalus of specific etiologies, will be 
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discussed in a subsequent publication. In this analysis, we attempted to systematically 
review the existing literature detailing the efficacy of CSF versus ETV shunts and to 
produce evidence-based recommendations for the selection of surgical procedures based 
on the strength of available data. Evidence for ETV and discussion of the procedure in 
infants under 1 year of age are discussed elsewhere. [7] The main objective of this study 
is to broadly assess the outcome of treatments and review evidence that one treatment 
may have greater efficacy than another. 
 
Methods 
Researchers develop PICO questions. How to compare the effectiveness of a 
ventriculoperitoneal shunt and endoscopic third ventriculostomy as a treatment for 
hydrocephalus in children in developing countries. Based on this, the PICO questions 
were obtained as follows: 
• Patients: Patients aged 0-18 years with hydrocephalus 
• Intervention: Ventriculoperitoneal shunt (VPS) 
• Comparison: Endoscopic third ventriculostomy (ETV) 
• Outcome: The success of the procedure was characterized by postoperative 
clinical improvement 
Researchers applied strict inclusion criteria, selected only RCTs, case-control 
studies or cohort studies, and pediatric patients with hydrocephalus were treated with 
these two invasive treatment options. Researchers used the following keywords: 
"Hydrocephalus" AND "Shunt" AND "Ventriculostomy". Researchers limit the research 
to only in English languages. Articles published between 2000 and 2020. One reviewer 
completes all review processes. The following databases were reviewed: Cochrane 
Library, Medline, Embase, Web of Science, Google Scholar, Scopus, and PubMed. 
Demographic information, detailed methods, interventions, and results were 
extracted from the selected manuscripts for review and recorded on a special data form. 
The data taken includes: 
1. Methods: Research design, description or research flow, sampling technique and 
the number of respondents included in the study. 
2. Patients: Patients aged 0-18 years with hydrocephalus 
3. Intervention: Ventriculoperitoneal shunt (VPS) 
4. Comparison: Endoscopic third ventriculostomy (ETV) 
5. Outcome: The success of the procedure was characterized by postoperative 
clinical improvement 
6. Conclusions from the study 
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Figure 1. The PRISMA flowchart in identifying the literature included 
Results 
Of the 122 articles identified using optimized search parameters, 52 were 
withdrawn for full-text review. The Task Force member assigned to the current topic 
read and discussed all 52 articles that were recalled for full-text review as well as 
additional studies who were identified and subsequently disqualified. Since the primary 
aim of this study was to assess treatment outcomes after CSF or ETV shunt placement, 
the scope of the evidentiary review was limited to studies reporting quantitative results 
on both procedures (n = 14). In total, 6 articles were accepted for inclusion in the 
evidentiary table and 8 were excluded for various reasons as described above. If more 
than 1 paper addresses the same clinical material or the same subject, only the paper 
with the largest patient population and current data are included in the evidentiary table. 
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The tabulated evidence provides sufficient data to allow our evaluation of the CSF 
versus ETV shunt. 
Two articles were excluded because they contained redundant material or were 
duplicate publications. If more than 1 paper addresses the same clinical material, only 
the paper with the largest patient population and current data are included in Table 1 as 
evidence to support the topic. Two other articles by the same research group were also 
excluded: one because of possible subject redundancy and insufficient data to address 
the main objective, and the other because it contained different outcome measures. Two 
articles were excluded because they evaluated the role of ETV or ETV and CSF shunts 
prior to posterior fossa surgery for tumor excision, a clinical scenario in which 
hydrocephalus may be expected to resolve in some cases. Finally, 1 article was 
excluded because the topic was the simultaneous implantation of ETV and CSF shunts, 
which prohibited the assessment of the outcome of either procedure alone. 
 
Discussion 
Cerebrospinal fluid shunts and ETV showed equivalent results in the clinical 
scenarios studied. All relevant articles, including those planned for inclusion and 
exclusion, were reviewed before finalizing the evidentiary table. Each article is 
presented and discussed in detail, and careful consideration is made to determine the 
data class of each article. Peralo, et al. (2018) reported a retrospective analysis of data 
obtained prospectively on 98 patients treated with VP shunt (76 patients) or ETV (22 
patients). The main result is an operation failure, which is recorded when further 
operation is required. The failure rates for VP shunt and ETV surgery were 58% and 
55%, respectively, with a mean follow-up of 4.7 years. The study group allocation was 
not controlled, and there was variability in the patient's age at surgery, the etiology of 
hydrocephalus, and other factors. [8] 
Biluts, et al. (2016) reported the results of a retrospective review of 55 
procedures (24 ETV and 31 VP shunt placement) performed on 48 patients in the 
context of a literature review. With a median follow-up of 39 months, the authors noted 
a trend toward lower failure rates in the ETV group (26% vs 42% in the VP shunt arm), 
although this was not significant. The authors acknowledged non-significant differences 
in patient age and sex as well as in the etiology of hydrocephalus between their groups. 
Shimizu et al. 17 (2012) presents a retrospective, 2-center review of cases in which ETV 
(9 patients) or VP shunt surgery (36 patients) was performed after removal of the 
infected shunt. No significant differences were observed between the 2 groups in 
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reinfection rates or length of procedure. Of note, however, 7 out of 9 ETV ultimately 
failed in the case series of patients treated after shunt infection. [9] 
Author, Years Research 
description 
Research type Results 
Peralo, et al. 2018 Retrospective 
analysis of a 
prospective case 
series of 98 patients 
treated with VP 
shunt or ETV. The 
main result: failure 
of the procedure for 
VP shunt or ETV. 
The timing of 











Failure rate: 55% 
ETV group, 58% 
shunt VP group. 
Hazard ratios were 






present in patient 
age, etiology of 
hydrocephalus & 
other factors. 
Biluts, et al. 2016 Retrospective 
review of 55 
procedures in 48 
consecutive patients 
(ETV: 24 patients; 




The difference in 
failure rates was not 
significant (26% 
with ETV vs 42% 
with VP shunt 
operation). There 
were no differences 
between groups at 6 
months, 1 year, 2 
years, or 5 years 
after surgery. 
 
Gmnelner, et al. 
2020 
Cohort analysis of 
ETV vs VP shunts 
with comparison of 
cost effectiveness & 
procedure failure 
rates with 28 




matched to a single 
institution. Study 
interval is extended 






The ETV success 
rate of 54% was not 
significantly 
different from VP 
shunt surgery. 








observed in cost or 
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model shows a 
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retrospective data 
for ETV & data 
obtained 
prospectively for 
shunts (from the 
Shunt Design Trial 











ETV; 2) data 
obtained 
prospectively from 
2 previous trials 
were reanalyzed in 
this study. 
ETV than for 
shunting. After 
adjusting for age & 
etiology of 
hydrocephalus, ETV 
had a higher early 
failure rate than 
shunting. However, 
the ETV failure rate 
was lower than that 
of shunting at the 
points after 3 
months 
postoperatively. 
Shimizu et al., 
2012 
Retrospective center 
2 study of ETV (n = 
9) & VP shunt (n = 
36) after removal of 
infected VP shunt. 
Compare reinfection 










the VP shunt 
(27.8%) & ETV 
(11.1%) groups. 
Procedure survival 
did not differ 
significantly 
between VP shunt 
(658 days) & ETV 
(929 days). 
Table 1. Comparison of hydrocephalus treatment in children with VPS and ETV 
 
Gmeiner, et al. (2020) report a retrospective, single-institution, matched cohort 
study in which ETV was compared with VP shunt surgery. With 28 patients in each 
group, no significant differences were noted between the 2 procedures in treatment 
success rates or in cost-effectiveness parameters such as length of stay, time of 
operation, or cost per patient. The authors acknowledge several limitations to the study, 
including simple sample size, long treatment intervals with deviation from practice over 
time, and the possibility of late ETV failure (there was 1 hydrocephalus-related death in 
this group). [10] 
The largest study included in the evidentiary table was conducted by Rei, et al. 
(2017). This large multicenter comparison study had 2 arms: a retrospective arm for 
ETV (n = 489), and an arm where prospectively obtained data for VP shunt was 
obtained from 2 previous clinical trials and reanalyzed for this study (n = 720). As 
mentioned earlier, several related studies by the same study group were excluded, 
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because there might be some overlap in the patients included in this study. Rei, et al. 
describes an analysis of ETV versus VP shunt operation on a large scale. The 
unadjusted baseline model showed lower failure rates for ETV compared to shunt 
surgery, but when adjusted for patient age and hydrocephalus etiology, the comparison 
became more complicated: early failure was higher for ETV than shunt placement, but 
at points after 3 month, the ETV failure rate is lower than that of shunt operation. Based 
on these findings, the authors concluded that there may be a survival advantage to long-
term treatment for ETV. [11] 
Finally, there are a number of limitations to this systematic review. In narrowing 
the scope of this project to focus specifically on evaluating hydrocephalus management 
methods - VP shunt or ETV - several key factors known to influence ETV success, 
namely patient age, hydrocephalus etiology, and previous history of hydrocephalus 
surgery, were not assessed. [12] The heterogeneity in the subject data we analyze here 
inherently limits the ability of these recommendations to inform surgical decision 
making in specific cases. Furthermore, emerging information regarding the role of 
cauterization of the choroid plexus (CPC) in relation to ETV and alternative indications 
for ETV with or without CPC (eg, prematurity post-hemorrhagic hydrocephalus) should 
be evaluated in future iterations of guidelines for the management of hydrocephalus as 
more information becomes available. Finally, and most significantly, there is an urgent 
need for large-scale randomized controlled trials to definitively answer the question of 
optimal surgical technique (VP shunt, ETV, or ETV-CPC) in the etiology of 
hydrocephalus any case. [13] 
Conclusion 
CSF shunt and endoscopic third ventriculostomy (ETV) are options in the 
management of hydrocephalus in children. Cerebrospinal fluid shunts and ETV showed 
equivalent results in the clinical scenarios studied. However, the results of studies in 
infants with hydrocephalus suggest that initial treatment with ETV makes more sense 
than shunt implantation. The results also show that ETV and shunt implantation are the 
right choices for treating hydrocephalus in children. However, ETV was better during 
the efficacy time. Computer simulations of hydrocephalus before and after shunt 
implantation and ETV treatment showed that the maximum CSF pressure was the most 
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